Castleark Management LLC
- SEC CIK
- 0001106832
- Latest filing
- Aug 14, 2026
RVNC holding history
Revance Therapeutics, Inc. in every 13F filed by Castleark Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVNC overviewAll 13F holders of RVNCFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −125,727−100.0% | Sold out | Holders |
| Q2 2023 | 125,727 | $3.18M | 0.1% | +23,140+22.6% | Added | Holders |
| Q1 2023 | 102,587 | $3.30M | 0.2% | +44,220+75.8% | Added | Holders |
| Q4 2022 | 58,367 | $1.08M | 0.1% | −79,980−57.8% | Reduced | Holders |
| Q3 2022 | 138,347 | $3.73M | 0.2% | +9,034+7.0% | Added | Holders |
| Q2 2022 | 129,313 | $1.79M | 0.1% | +129,313 | New | Holders |